SPH-3261

N/A

Report date: 2024/01/05 15:55:45
NME

Base Information

Drug NameSPH-3261
Drug Alias NameSPH-3261I-025
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 antagonists
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesShanghai Pharmaceuticals Holding Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesSph (Benxi) North Pharmaceutical Co LtdShanghai Pharmaceuticals Holding Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A